SignalCorporate
Novo Sends Oral Wegovy Into China's GLP-1 Race Behind Lilly
Novo's oral Wegovy enters China's GLP-1 race, directly challenging Lilly's market position.
What changed
Novo's oral Wegovy enters China's GLP-1 race, directly challenging Lilly's market position.
Why it matters
Novo's oral Wegovy enters China's GLP-1 race, directly challenging Lilly's market position. — impact context not separately stored; see What changed.
← Dashboard
Sep 03, 2026 06:13 AM ET